Coronary Artery Bypass Graft Surgery Clinical Trial
Official title:
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Heparin/Platelet Factor 4 (PF4) antibody testing will be performed in subjects who have just undergone coronary artery bypass grafting (CABG) surgery. 30 subjects with a positive antibody result and no signs or symptoms of Heparin Induced Thrombocytopenia (HIT) will be randomized to receive argatroban and warfarin. 30 subjects with a positive antibody result and no signs or symptoms of HIT will be randomized to receive no treatment. 30 subjects with a negative antibody result will also be followed in the study. All subjects will have a cardiac CT scan at about 30 days post surgery to measure the patency of their coronary artery bypass vein grafts. This study will evaluate if treating patients who have heparin PF4 antibodies post-CABG with argatroban and warfarin has any effect on the short-term patency of coronary artery bypass vein grafts.
This is a prospective, randomized, single center study. Patients scheduled for CABG will be screened and enrolled. Subjects positive for heparin/PF4 antibody within 24 h after CABG and without clinical suspicion of HIT will be randomized into one of two groups. An additional 30 patients with negative antibody titers will serve as a control group. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00248885 -
Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)
|
N/A | |
Completed |
NCT04473287 -
The Effect of Reflexology After Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT03892460 -
Transitional Rehabilitation in CABG Patients
|
N/A | |
Completed |
NCT04238806 -
Desflurane,Brain Natriuretic Peptide and Cardiac Surgery
|
N/A | |
Completed |
NCT00402506 -
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
|
Phase 3 | |
Recruiting |
NCT03900026 -
Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery
|
Phase 4 | |
Completed |
NCT01095419 -
Effects of Massage Therapy on Sleep After Heart Surgery
|
N/A | |
Recruiting |
NCT05377983 -
The Effect of Lavender Oil Inhalation on Pain, Anxiety and Sleep Quality After Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT03123107 -
Vitamin C in Cardiac Surgery Patients
|
Phase 1 | |
Terminated |
NCT00735722 -
A(f)MAZE-CABG Study
|
N/A | |
Recruiting |
NCT04652375 -
Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures
|
N/A | |
Completed |
NCT05830682 -
Effect of Using Walking Aid on Mobility
|
N/A | |
Completed |
NCT05191745 -
Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery
|
Phase 3 | |
Enrolling by invitation |
NCT01127802 -
Changes of Functional Status, Symptoms Distress and Quality of Life in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
|
N/A | |
Active, not recruiting |
NCT00396760 -
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
|
Phase 3 | |
Completed |
NCT04111744 -
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Active, not recruiting |
NCT01063491 -
Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study
|
Phase 3 | |
Completed |
NCT00618592 -
Does Pre-operative Carbohydrate Loading Reduce Insulin Resistance and Improve Outcomes in Elective Surgical Patients?
|
N/A | |
Withdrawn |
NCT04717817 -
Inspiratory Muscle Training Prior to Conventional and Minimal Invasive Heart Surgery
|
N/A | |
Withdrawn |
NCT00807521 -
Steroid-induced Reduction of Surgical Stress Study
|
N/A |